Sign in

CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company

ZEVRA THERAPEUTICS, INC.

Sign in to watch
Ticker
ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205894398
Phone
(888) 958-1253
Business address
101 FEDERAL STREET, BOSTON, MA, 02110
Former names
KEMPHARM, INC, KEMPHARM INC
  1. DEFA14A Proxy Proxy Materials
  2. 8-K Event Other events
  3. 425 Deal Prospectus/Communication re Business Combination
  4. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 8-K Event Executive or director change
  10. 4 Open-market buy CCO & EVP, Bus. Development bought 1,000 shares at $5.42 ($5,416)
  11. 4 Open-market buy Director bought 275 shares at $5.95 ($1,636)
  12. 4 Open-market buy Director bought 325 shares at $5.52 ($1,794)
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Director bought 400 shares at $5.11 ($2,042)
  15. 4 Open-market buy Director bought 10,000 shares at an average $5.04 ($50,418)
  16. 4 Open-market buy CFO, Secretary & Treasurer bought 2,740 shares at an average $4.95 ($13,562)
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations · Executive or director change
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 12 of 44 · 870 filings